GlaxoSmithKline Pharmaceuticals sells trademarks pertaining to 'lodex', 'Ostocalcium' brands in India

17 Mar 2022 Evaluate

GlaxoSmithKline Pharmaceuticals has completed the transaction relating to sale of the Company's trademarks 'pertaining to 'lodex' and 'Ostocalcium' brands in India to GlaxoSmithKline Asia. Earlier, in July 2021, the company had received approval to transfer of the trademarks pertaining to 'lodex' and 'Ostocalcium' brands in India.

GlaxoSmithKline Pharmaceuticals is an Indian subsidiary of GlaxoSmithKline plc. The company business has a broad portfolio of innovative and established medicines, with leadership positions in respiratory and HIV.

Glaxosmithkline Phar Share Price

2279.85 -101.05 (-4.24%)
23-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1756.35
Dr. Reddys Lab 1252.55
Cipla 1222.70
Zydus Lifesciences 860.55
Lupin 2297.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×